Okyo Pharma Share Discussion Threads

[p5tvr] 17/2/2023 15:53

g2 will be a long later to say she's brought 100k worth!!... LOL :0)

[faraweigh2] 13/1/2023 16:56

3 dollars hit on Nasdaq.
In September last year, LSE hit upwards of 4.2p to coincide.
See how this plays out, but hoping 4.2p plus by end February and nudging up toward 7p by end Q1.
Time only will tell ; )

[faraweigh2] 13/1/2023 14:42

Going to break 3 dollars ask on Nasdaq soon.Means we're way behind the curve here. Interesting sessions ahead!

[faraweigh2] 13/1/2023 11:23

Requoted in part from S/T:
OKYO Pharma (OKYO): 2.75p Target 7p
A problem with the bear market in small caps is that some timelines have been stretched, as well as valuations kept a lid on until companies are much further down the line as far as their milestones. A good example of both delayed market response and depressed share price is dry eye treatment group OKYO. Of course, it may be the case that even after the latest announcement of clearance of its Investigational New Drug (IND) application from the FDA to initiate a Phase 2 human clinical study. What the market has perhaps still not cottoned onto are a few factors here with OKYO. The dry eye treatment market is a multi-billion dollar one, with the jump in technology with OK-101 which is a treatment, rather than current applications which mere address the symptoms of dry eyes in a mechanical way. Just as important is that because OK-101 is a topical treatment it will have accelerated FDA approval, a point underlined by this month’s news from the company. Such an accelerated approved clearly means that the costs of development are that much more economic. Finally, given the way that the market cap is back to where it was two years ago, despite the advances made, we could see a realignment in 2023, especially given the drug will be “moving into the clinic in the first quarter of 2023"?

[faraweigh2] 13/1/2023 09:23

4.2p and 7p sighted recently as possible next steps.Time will tell!

[p5tvr] 05/1/2023 13:05

You don't say Sherlock!! :0)

[zen12] 22/12/2022 14:44

Zak Mir 4.2p+ targethttps://www.youtube.com/embed/DN8jGt1o-F4

[bibs] 22/12/2022 14:29

Pre Market NASDAQ suggests news is being well received.

[faraweigh2] 24/11/2022 09:21

I clocked that too bibs and in Black and White!
Same price as Exec Chair's recent purchase and plus 225 percent higher than current mid-price.
A complete game changer when the current filing is approved and recognised.
2023 looks promising as I said!

[bibs] 24/11/2022 08:20

Exercise price of 6.25 pence...

[faraweigh2] 21/11/2022 15:30

Hey Bell End, see post 571 below.
Took plenty of profit between 4 and 4.31 from 2.8 so all good thank you.
Stuck profit in HARL so even better lol.
Watch and learn jockey!
PS: this will be double current share price by end March 23.

[blackhorse23] 21/11/2022 08:10

Thinking to buy MCL (LSE)

[kasspass] 03/11/2022 18:01

Seems no one interested in this camel ears anymore. one wonders what happened on that ThinkEquity conference.. we should have had at least a feedback.

[faraweigh2] 12/9/2022 12:02

Good post bibs.Watched this a couple of times and be interesting to see how NASDAQ reacts over coming trading sessions. Most probably viewed extremely positively, we'll soon see.Onwards and Upwards!

[bibs] 12/9/2022 10:01

https://youtu.be/qC6PYmkS4sY

[faraweigh2] 07/9/2022 15:34

15:31 hrs and 3 dollars breached on NASDAQ.Up over 5 percent an hour into trading session.

[bibs] 07/9/2022 13:41

AGM resolutions all passed, so 'good to go'!

[faraweigh2] 07/9/2022 08:25

Expect to see 4p behind us here and 3 dollars broken in the US short term.

[faraweigh2] 06/9/2022 17:12

350k Buys late in the day, nice.An interesting 6 months ahead no doubt.

[faraweigh2] 02/9/2022 09:23

Late reported 1.8 million Buy trade just popped up.Hence the plus 12 percent rise in to LSE close yesterday.Bullish sentiment is building now.

[faraweigh2] 01/9/2022 16:13

Long and strong over on NASDAQ.Investors understand the prospect over there.Volumes increasing and with an upward trajectory too.